Ongoing cases

AUTH/3174/3/19 - Anonymous Employees v Otsuka Europe
Description:Conduct of Otsuka Europe
Case Status:Breach ruled, case report pending
Last Updated:21/11/2019
AUTH/3169/3/19 - Voluntary admission from Otsuka Europe
Description:Revision of Jinarc SPC
Case Status:Breach ruled, case report pending
Last Updated:20/11/2019
AUTH/3153/1/19 - Anonymous v Otsuka Europe
Description:Out-of-date promotional materials
Case Status:Breach ruled, case report pending
Last Updated:20/11/2019
AUTH/3151/1/19 - Anonymous Employees v Otsuka Europe
Description:SPC changes and prescribing information
Case Status:Breach ruled, case report pending
Last Updated:21/11/2019
AUTH/3140/12/18 - Health professional v Amgen
Description:Information on Disclosure UK
Case Status:Breach ruled, case report pending
Last Updated:31/10/2019
AUTH/3025/3/18 - Member of the public v Merck Sharp & Dohme
Description:Promotion of Nexplanon
Case Status:No breach, outwith the scope of the Code
Last Updated:28/06/2018
AUTH/3021/2/18 - Anonymous v Shire
Description:Meeting advertised on LinkedIn
Case Status:No breach, outwith the scope of the Code
Last Updated:28/06/2018
AUTH/3020/2/18 - Anonymous v Lilly
Description:Meeting advertised on LinkedIn
Case Status:No breach, outwith the scope of the Code
Last Updated:28/06/2018
AUTH/3019/2/18 - Anonymous v Boehringer Ingelheim
Description:Meeting advertised on LinkedIn
Case Status:No breach, outwith the scope of the Code
Last Updated:28/06/2018
AUTH/3016/1/18 - Consultant Haematologist v Takeda
Description:Alleged religious discrimination
Case Status:No breach, outwith the scope of the Code
Last Updated:02/10/2018
AUTH/3007/12/17 - Director v Vifor Fresenius
Description:Clinical trial disclosure (Velphoro)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/3006/12/17 - Director v Lilly
Description:Clinical trial disclosure (Trulicity)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/3004/12/17 - Director v Gilead
Description:Clinical trial disclosure (Sovaldi)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/3003/12/17 - Director v Clinuvel UK
Description:Clinical trial disclosure (Scenesse)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/3002/12/17 - Director v Octapharma
Description:Clinical trial disclosure (Nuwiq)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/3001/12/17 - Director v Sunovion
Description:Clinical trial disclosure (Latuda)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/3000/12/17 - Director v Roche
Description:Clinical trial disclosure (Gazyvaro)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/2999/12/17 - Director v Otsuka
Description:Clinical trial disclosure (Deltyba)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/2998/12/17 - Director v Lilly
Description:Clinical trial disclosure (Cyramza)
Case Status:No breach, outwith the scope of the Code
Last Updated:13/04/2018
AUTH/2967/8/17 - Consultant v Shire
Description:Omission of prescribing information and other obligatory information
Case Status:No breach, outwith the scope of the Code
Last Updated:11/12/2017
AUTH/2966/8/17 - Consultant v Takeda
Description:Promotion of vedolizumab
Case Status:No breach, outwith the scope of the Code
Last Updated:11/12/2017
AUTH/2909/11/16 - Director v Astellas UK
Description:Clinical trial disclosure (Xtandi)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2907/11/16 - Director v Takeda
Description:Clinical trial disclosure (Vipidia)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2905/11/16 - Director v A Menarini
Description:Clinical trial disclosure (Spedra)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2904/11/16 - Director v Lundbeck
Description:Clinical trial disclosure (Selincro)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2900/11/16 and AUTH/2910/11/16 - Director v Sanofi
Description:Clinical trial disclosure (Lyxumia) and (Zaltrap)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2899/11/16 - Director v Aegerion
Description:Clinical trial disclosure (Lojuxta)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2896/11/16 - Director v Janssen
Description:Clinical trial disclosure (Invokana)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2895/11/16 - Director v Boehringer Ingelheim
Description:Clinical trial disclosure (Giotrif)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2894/11/16 - Director v Mitsubishi Tanabe
Description:Clinical trial disclosure (BindRen)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2891/11/16 - Ex-employee v Astellas
Description:Certification and review of materials
Case Status:No breach, outwith the scope of the Code
Last Updated:24/01/2017
AUTH/2881/10/16 - Anonymous, non-contactable v Shire
Description:Alleged Shire video on a public website
Case Status:No breach, outwith the scope of the Code
Last Updated:22/11/2016
AUTH/2858/7/16 - Health Professional v Bayer
Description:Alleged promotion to the public
Case Status:No breach, outwith the scope of the Code
Last Updated:12/10/2016